Identification of key genes of papillary thyroid cancer using integrated bioinformatics analysis

W Liang, F Sun - Journal of endocrinological investigation, 2018 - Springer
Objective To identify novel clinically relevant genes in papillary thyroid carcinoma from
public databases. Methods Four original microarray datasets, GSE3678, GSE3467 …

[HTML][HTML] Comprehensive pan-cancer analysis and the regulatory mechanism of ASF1B, a gene associated with thyroid cancer prognosis in the tumor micro …

J Ma, W Han, K Lu - Frontiers in oncology, 2021 - frontiersin.org
Background The incidence of thyroid cancer, whose local recurrence and metastasis lead to
death, has always been high and the pathogenesis of papillary thyroid carcinoma (PTC) has …

[HTML][HTML] Identification of a six gene prognosis signature for papillary thyroid cancer using multi-omics methods and bioinformatics analysis

H Ren, X Liu, F Li, X He, N Zhao - Frontiers in Oncology, 2021 - frontiersin.org
Papillary thyroid carcinoma (PTC) is the most common subtype of thyroid cancer. PTC is
typically curable with an excellent survival rate; however, some patients experience disease …

Expressions of miRNAs in papillary thyroid carcinoma and their associations with the clinical characteristics of PTC

J Hu, C Li, C Liu, S Zhao, Y Wang, Z Fu - Cancer Biomarkers, 2017 - content.iospress.com
BACKGROUND: The sensitivity and specificity of biomarkers which have been used in
clinical practice for diagnosis of papillary thyroid carcinoma (PTC) are low, it is essential to …

[HTML][HTML] Preoperative lymph node staging by FDG PET/CT with contrast enhancement for thyroid cancer: a multicenter study and comparison with neck CT

A Chong, JM Ha, YH Han, E Kong, Y Choi… - Clinical and …, 2017 - ncbi.nlm.nih.gov
Objectives The purpose of this study was to compare lymph node (LN) staging using 18 F-
fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) …

[图书][B] HNO-Operationslehre: mit allen wichtigen Eingriffen

G Rettinger, W Hosemann, KB Hüttenbrink, JA Werner… - 2017 - thieme-connect.com
Jede Operation ist in einem eigenen Kapitel rundum aufgearbeitet, sodass beim Lesen
problemlos zwischen den Eingriffen hin und her gesprungen werden kann. Indikationen …

Individualized follow-up strategy for patients with an indeterminate response to initial therapy for papillary thyroid carcinoma

HS Oh, JH Ahn, E Song, JM Han, WG Kim, TY Kim… - Thyroid, 2019 - liebertpub.com
Background: The concept of a dynamic risk-stratification scheme has been suggested for
individualized management of patients with papillary thyroid carcinoma (PTC). However …

Integrative Analysis of Potential Biomarkers Involved in the Progression of Papillary Thyroid Cancer

R Bansal, U Saxena - Applied biochemistry and biotechnology, 2023 - Springer
This study aims to explore key prognostic and diagnostic biomarkers involved in the
pathogenesis of papillary thyroid cancer (PTC) which is one of the most common endocrine …

[PDF][PDF] Guía de manejo del nódulo tiroideo y del cáncer diferenciado de tiroides de la Sociedad Mexicana de Oncología

M Granados-García, JF Gallegos-Hernández… - Gac Mex …, 2018 - biblat.unam.mx
El cáncer diferenciado de tiroides (CDt) muestra un reciente y rápido incremento en su
incidencia. Generalmente está asociado a un buen pronóstico de supervivencia (SV), pero …

Diagnostic significance of elevated expression of HBME-1 in papillary thyroid carcinoma

YJ Chen, RM Zhao, Q Zhao, BY Li, QY Ma, X Li… - Tumor Biology, 2016 - Springer
This study examined the association between hector battifora mesothelial antigen-1 (HBME-
1) expression and papillary thyroid carcinoma (PTC). A total of 206 patients were enrolled in …